BiotechTube
Home/SanegeneBio/Marc Abrams, Ph.D.
MA

Marc Abrams, Ph.D.

Chief Technology Officer and Head of US Operations

SanegeneBio

Therapeutic Areas

Metabolic DiseasesObesityAutoimmune DiseasesCardiovascular Diseases

SanegeneBio Pipeline

DrugIndicationPhase
Undisclosed (Obesity/Metabolic)Obesity/Metabolic DisordersPhase 2
Undisclosed (Complement)Complement-Mediated Immune DiseasePhase 1
Undisclosed (Cardiometabolic)Cardiometabolic DiseasePhase 1

Leadership Team at SanegeneBio

WW
Weimin Wang, Ph.D.
Founder, Chief Executive Officer
SW
Shiyu Wang, Ph.D.
Co-Founder, Chief Scientific Officer
YJ
Yuyan Jin, Ph.D.
Senior Vice President of Clinical and Non-Clinical Development
View full SanegeneBio profile